ライフサイエンスコーパス: immunoglobulin A

1 other salivary proteins, including secretory immunoglobulin A.

2 aximal development of RV-specific intestinal immunoglobulin A.

3 or the milk as immunoglobulin G and secreted immunoglobulin A.

4 the protein has been shown to bind secretory immunoglobulin A.

5 the apical recycling marker, membrane-bound immunoglobulin A (a ligand for the polymeric immunoglobu

6 its analysed were faecal egg count (FEC) and immunoglobulin A activity against third-stage larvae fro

7 sies in children with symptoms and levels of immunoglobulin A against tissue-transglutaminase (TGA-Ig

8 Therefore, a complex enriched in secretory immunoglobulin A and alpha-amylase forms a S. sanguis-bi

9 In addition, immunoglobulin A and bactericidal antibodies were detect

10 in reactions, and mucosal defense (secretory immunoglobulin A and dual-sugar permeability).

11 fic circulating immunoglobulin G and vaginal immunoglobulin A and G antibodies.

12 In the MR + HRV group, antirotavirus immunoglobulin A and IgG seropositivity frequencies befo

13 Elevated serum immunoglobulin A and immunoglobulin G titers were associ

14 rforation plus immunoglobulins enriched with immunoglobulin A and immunoglobulin M (250 mg/kg, intrav

15 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M (p < .01).

16 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M alleviated the sym

17 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M improve the integr

18 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M on blood-brain bar

19 oglobulin G or immunoglobulins enriched with immunoglobulin A and immunoglobulin M treatment, no ultr

20 globulin G and immunoglobulins enriched with immunoglobulin A and immunoglobulin M, respectively (p <

21 erol levels and gallstones risk; and between immunoglobulin A and juvenile idiopathic arthritis).

22 Flow rate and salivary concentrations of immunoglobulins A and G, albumin, amylase, lysozyme, lac

23 Serum levels of immunoglobulin M, immunoglobulin A, and immunoglobulin G against C. diffic

24 um total free light chain, immunoglobulin G, immunoglobulin A, and immunoglobulin M were measured on

25 CT adjuvant, substantial levels of salivary immunoglobulin A anti-AgI/II antibodies were induced.

26 unosorbent assay titers in serum and mucosal immunoglobulin A antibodies against H3N2 SIV antigens.

27 Norwalk VLP-specific immunoglobulin G and immunoglobulin A antibodies increased 4.8- and 9.1-fold,

28 c mean mucosal (fecal and salivary) anti-HWC immunoglobulin A antibodies occurred among H. pylori-inf

29 ke virus, and sera were drawn and tested for immunoglobulin A antibodies to the outbreak strain.

30 ced a local mucosal response as evidenced by immunoglobulin A antibody in saliva, nasal washes, and l

31 Immunoglobulin A antibody levels that are elevated befor

32 unoglobulin G and A, and nasal wash specimen immunoglobulin A antibody responses to the HMPV F protei

33 A dose-related, immunoglobulin A antibody-secreting cell (ASC) response

34 blood flow had more abdominal discomfort and immunoglobulin A-antilipopolysaccharide (r = 0.76, p < 0

35 ed the 50- or 100-mug vaccine dose developed immunoglobulin A ASCs.

36 his relationship was particularly strong for immunoglobulin A clones (R, 1; P < 0.0005), suggesting t

37 advantageous in vivo, and increased anti-CPS immunoglobulin A correlated with increased fitness of a

38 Selective immunoglobulin A deficiency (IgAD) is the most common pr

39 tand the genetic predisposition to selective immunoglobulin A deficiency (IgAD), we performed a genom

40 -syndrome, common variable immunodeficiency, immunoglobulin A deficiency, or X-linked hyper-IgM syndr

41 s membrane pemphigoid, lichen planus, linear immunoglobulin A disease, and chronic ulcerative stomati

42 ases studied except for pemphigus and linear immunoglobulin A disease.

43 Immunoglobulin A enzyme-linked immunosorbent assays to A

44 Immunoglobulin A, for example, was induced to a signific

45 ssay to measure levels of total antireovirus immunoglobulin A, G, and M in serum specimens collected

46 Fragments from the immunoglobulin A gene were also found to have RNA polyme

47 Mice lacking immunoglobulin A had no defect in their ability to contr

48 tions containing T. cruzi-specific secretory immunoglobulin A harvested from immune mice were shown t

49 Basolateral-to-apical transcytosis of immunoglobulin A (IgA) (a ligand for the polymeric immun

50 significantly higher fecal parasite-specific immunoglobulin A (IgA) (days 27, 31, 35, and 42 postinoc

51 stinal M cells bear a receptor for secretory immunoglobulin A (IgA) (sIgA) facing the lumen of the ep

52 Transport of immunoglobulin A (IgA) across the mucosa to the gut lume

53 samples were collected in October from which immunoglobulin A (IgA) activity was measured and DNA was

54 liva AMA showed that 80% of the patients had immunoglobulin A (IgA) against PDC-E2, 18% had IgM-speci

55 al extracts were assayed for total secretory immunoglobulin A (IgA) and C. parvum-specific IgA reacti

56 llele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy subjects (

57 scribe patterns and determinants of cervical immunoglobulin A (IgA) and G (IgG) levels during the men

58 ificantly higher plasma and mucosal anti-SBR immunoglobulin A (IgA) and IgG Ab responses than SBR alo

59 ated the prevalence of abnormally high serum immunoglobulin A (IgA) and IgG anti-gliadin antibody tit

60 gh i.vag. immunization induced local vaginal immunoglobulin A (IgA) and IgG antibody responses, these

61 e rats primed and boosted vaginally, vaginal immunoglobulin A (IgA) and IgG antibody titers to HGH we

62 allenge, total HRV- and HRV protein-specific immunoglobulin A (IgA) and IgG ASCs in intestinal lympho

63 Influenza virus-specific effector immunoglobulin A (IgA) and IgG circulating antibody-secr

64 d a significantly dose-dependent increase of immunoglobulin A (IgA) and IgG in the nasal wash, lung l

65 ficient mice had elevated baseline levels of immunoglobulin A (IgA) and IgG in the serum and increase

66 toxin (CT), elicited comparable SEB-specific immunoglobulin A (IgA) and IgG levels in saliva.

67 all volunteers who received H10407 had serum immunoglobulin A (IgA) and IgG responses, and all but on

68 ids contained significantly higher levels of immunoglobulin A (IgA) and IgG specific for each protein

69 induction of antigen-specific genital tract immunoglobulin A (IgA) and IgG.

70 tained within the vaccine vector, diminished immunoglobulin A (IgA) and IgG1 antibody titers, as well

71 A (ConA) plus CT enhanced the production of immunoglobulin A (IgA) and IgM by dividing cells that ex

72 Influenza virus-specific immunoglobulin A (IgA) and immunoglobulin G (IgG) antibo

73 Serum immunoglobulin A (IgA) and immunoglobulin G (IgG), fecal

74 revalence and level of intestinal antilectin immunoglobulin A (IgA) and serum anti-LC3 (cysteine-rich

75 Fecal immunoglobulin A (IgA) and serum IgG antibodies were fir

76 ed with elevated levels of antitoxin mucosal immunoglobulin A (IgA) and serum IgG antibodies.

77 were collected; anti-P. gingivalis salivary immunoglobulin A (IgA) and serum IgG were quantified.

78 ccinated mice produced CRR-specific salivary immunoglobulin A (IgA) and serum IgG.

79 explains the observed elevations in mucosal immunoglobulin A (IgA) and serum IgG1 antibodies.

80 Peyer's patches (PP) were analyzed for total immunoglobulin A (IgA) and SFB-specific IgA production.

81 Secretory immunoglobulin A (IgA) and systemic IgG2a antibody devel

82 or optimal induction of protective secretory immunoglobulin A (IgA) and systemic type 1 immunity prot

83 seroconverted, and 100% coproconverted with immunoglobulin A (IgA) and/or IgG antibodies to HuNoV-HS

84 The levels of immunoglobulin A (IgA) anti-C-GTF activity in the nasal

85 gher levels of salivary, plasma, and vaginal immunoglobulin A (IgA) anti-C-GTF responses and higher l

86 o-GLU are attributed to the induced salivary immunoglobulin A (IgA) anti-GLU responses.

87 Immunoglobulin A (IgA) antibodies are presumed to be imp

88 that were recognized by intestinal secretory immunoglobulin A (IgA) antibodies from immune human subj

89 2-fold increase in influenza virus-specific immunoglobulin A (IgA) antibodies in nasal wash.

90 c virus-neutralizing antibodies in serum and immunoglobulin A (IgA) antibodies in secretions at the r

91 c virus neutralizing antibodies in serum and immunoglobulin A (IgA) antibodies in secretions at the r

92 had comparable levels of chlamydia-specific immunoglobulin A (IgA) antibodies in their vaginal washe

93 generate massive amounts of noninflammatory immunoglobulin A (IgA) antibodies through multiple folli

94 a were tested for immunoglobulin G (IgG) and immunoglobulin A (IgA) antibodies to Cryptosporidium and

95 Immunoglobulin A (IgA) antibodies to tissue transglutami

96 Immunoglobulin A (IgA) antibodies, produced in the lamin

97 functions, including induction of protective immunoglobulin A (IgA) antibodies.

98 e for a protective role for Candida-specific immunoglobulin A (IgA) antibodies.

99 We used a human monoclonal immunoglobulin A (IgA) antibody (NAD) to type 8 Streptoc

100 Anti-AgI/II immunoglobulin A (IgA) antibody activity in saliva and v

101 immunity to ricin correlates with secretory immunoglobulin A (IgA) antibody levels in vivo, the pote

102 nked immunosorbent assay that the intestinal immunoglobulin A (IgA) antibody response to the Entamoeb

103 consistently displayed greater anti-envelope immunoglobulin A (IgA) antibody responses in bronchoalve

104 V1 and RV5 to correlate anti-rotavirus serum immunoglobulin A (IgA) antibody titers vs efficacy in re

105 After nasal immunization, antigen-specific immunoglobulin A (IgA) antibody-forming cells dominated

106 Large quantities of immunoglobulin A (IgA) are constitutively secreted by in

107 rum-neutralizing antibody and anti-rotavirus immunoglobulin A (IgA) are the current standard for asse

108 Group 1 and 2 pigs had significantly fewer immunoglobulin A (IgA) ASC in intestinal tissues at PID

109 lated the highest mean numbers of intestinal immunoglobulin A (IgA) ASCs prechallenge among all vacci

110 Our data suggest that anti-FVIII immunoglobulin A (IgA) autoantibodies are predictors of

111 Antibodies of the immunoglobulin A (IgA) class react with capsular polysac

112 the active gut mucosal immune responses, and immunoglobulin A (IgA) coating of SFB in the gut.

113 Mucosal immunoglobulin A (IgA) deficiency in the gut resulted in

114 The levels of immunoglobulin A (IgA) detected in rectal secretions of

115 for neutralization of poliovirus and mucosal immunoglobulin A (IgA) detection.

116 Intestinal immunoglobulin A (IgA) ensures host defense and symbiosi

117 Significantly, mice genetically deficient in immunoglobulin A (IgA) expression were unable to survive

118 rgans for the generation of T cell-dependent immunoglobulin A (IgA) for gut homeostasis.

119 Immunoglobulin A (IgA) has been implicated in resistance

120 es, we demonstrated that increased levels of immunoglobulin A (IgA) in gingival crevicular fluid (GCF

121 ne immunogenicity, the quantity of rotavirus immunoglobulin A (IgA) in stool specimens obtained, at 1

122 ixture of these strains, developed secretory immunoglobulin A (IgA) in tears and serum IgG antibodies

123 Immunoglobulin A (IgA) induction primarily occurs in int

124 Immunoglobulin A (IgA) is a glycoprotein of which altere

125 Human immunoglobulin A (IgA) is an abundant antibody that medi

126 Immunoglobulin A (IgA) is prominently secreted at mucosa

127 locally driven response in the mucosa, where immunoglobulin A (IgA) is the dominant antibody isotype.

128 Immunoglobulin A (IgA) is the main intestinal antibody.

129 Immunoglobulin A (IgA) is the most abundant immunoglobul

130 The results showed that immunoglobulin A (IgA) is the predominant M. catarrhalis

131 Immunoglobulin A (IgA) is the primary immune response in

132 negative regulator of class switching to the immunoglobulin A (IgA) isotype.

133 The salivary immunoglobulin A (IgA) level was measured by an enzyme-l

134 inked immunosorbent assay (ELISA), and fecal immunoglobulin A (IgA) levels determined by ELISA.

135 Induction of antiurease immunoglobulin A (IgA) levels in gastric luminal secreti

136 in the HIV-1+ infants, whereas antirotavirus immunoglobulin A (IgA) levels were not.

137 amina propria lymphocytes, lowers gut and RT immunoglobulin A (IgA) levels, and destroys established

138 ffects of epitope-specific murine antilectin immunoglobulin A (IgA) monoclonal antibodies (MAbs) on a

139 The molecular mechanism(s) of immunoglobulin A (IgA) nephropathy, the most common prim

140 TG2-specific immunoglobulin A (IgA) of plasma cells (PCs) from CD les

141 mmals and birds, these species are devoid of immunoglobulin A (IgA) or a functional equivalent.

142 uce detectable levels of mucosal or systemic immunoglobulin A (IgA) or IgG antibody responses to eith

143 ng a multiplex immunoassay, we tested plasma immunoglobulin A (IgA) or immunoglobulin G (IgG) levels

144 nced the magnitude of mucosal virus-specific immunoglobulin A (IgA) production but did not alter the

145 nodes (MLNs) are thought to be essential for immunoglobulin A (IgA) production.

146 gene with high homology to the meningococcal immunoglobulin A (IgA) protease gene, which is distinct

147 The immunoglobulin A (IgA) protease secreted by pathogenic N

148 h protein shared homology to the serine-type immunoglobulin A (IgA) proteases of Neisseria gonorrhoea

149 BatB is predicted to share similarity with immunoglobulin A (IgA) proteases, and we showed that Bat

150 Secretory immunoglobulin A (IgA) protects the mucosal surfaces aga

151 Immunoglobulin A (IgA) provides protection against patho

152 All macaques generated a mucosal anti-SIV immunoglobulin A (IgA) response in rectal secretions.

153 f of the volunteers mounted a positive serum immunoglobulin A (IgA) response to S. flexneri lipopolys

154 fected with C. rodentium develop a secretory immunoglobulin A (IgA) response, but the role of B cells

155 al immunization induced greater HIV-specific immunoglobulin A (IgA) responses in mucosal secretions a

156 gut and the subsequent induction of mucosal immunoglobulin A (IgA) responses remain a major concern.

157 Protective immunoglobulin A (IgA) responses to oral antigens are us

158 We also measured immunoglobulin A (IgA) responses to the parasite, as IgA

159 Salivary immunoglobulin A (IgA) responses were not detected after

160 ut causing disease while eliciting secretory immunoglobulin A (IgA) responses, as evidenced by gut ti

161 -12 (IL-12) can stimulate elevated secretory immunoglobulin A (IgA) responses.

162 Mucosal immunoglobulin A (IgA) secreted by local plasma cells (P

163 ction and abrogates M. tuberculosis-specific immunoglobulin A (IgA) secretion to respiratory airways

164 We compared serum antirotavirus immunoglobulin A (IgA) seroconversion (>/=20 U/mL) and g

165 [OR], 0.77; P = .002) and lack of rotavirus immunoglobulin A (IgA) seroconversion (OR, 1.95; P = .01

166 imary objective was to compare antirotavirus immunoglobulin A (IgA) seroconversion at 18 weeks in the

167 2D6 is a dimeric monoclonal immunoglobulin A (IgA) specific for the nonreducing term

168 ncrease in meningococcus-specific intranasal immunoglobulin A (IgA) titers, while 23 of 42 demonstrat

169 e and 551 HIV-negative women were tested for immunoglobulin A (IgA) to human papillomavirus (HPV) typ

170 Although apical recycling of immunoglobulin A (IgA) was largely unaffected in cells e

171 nerve stimulations on salivary secretion of immunoglobulin A (IgA) was studied in the submandibular

172 cells producing antilipopolysaccharide (LPS) immunoglobulin A (IgA) were detected in 100 and 92% of r

173 Mice that lack immunoglobulin A (IgA) were fully protected, suggesting

174 ll responses by increasing the production of immunoglobulin A (IgA) while decreasing the production o

175 BCP also binds human immunoglobulin A (IgA), a characteristic that may be und

176 This dialog causes massive production of immunoglobulin A (IgA), a non-inflammatory antibody spec

177 CD8(-/-) mice had increased serum levels of immunoglobulin A (IgA), AMA and interleukin-17 (IL-17).

178 antibody and NS for neutralizing (neut), NI, immunoglobulin A (IgA), and immunoglobulin G (IgG) anti-

179 osal vaccine evoked high secretory titers of immunoglobulin A (IgA), as well as high circulating tite

180 d significant roles of RV-specific secretory immunoglobulin A (IgA), CD4+ T cells, and CD8+ T cells i

181 studied using T helper 1 cytokines/secretory immunoglobulin A (IgA), histatins and lysozyme in a subs

182 nt assay for group C polysaccharide-specific immunoglobulin A (IgA), IgA1, IgA2 and secretory compone

183 vaccine elicited S. flexneri 2a LPS-specific immunoglobulin A (IgA), IgG, and IgM antibody-secreting

184 challenge, production of rotavirus-specific immunoglobulin A (IgA), IgG, and IgM by small intestinal

185 ermine the phenotype of leukocytes and total immunoglobulin A (IgA), IgG, and IgM titers in the saliv

186 de cell numbers; and increased production of immunoglobulin A (IgA), IgG1, and IL-12 p40 from colon f

187 Three defense functions of immunoglobulin A (IgA), immune exclusion, intracellular

188 , the receptor specific for the Fc region of immunoglobulin A (IgA), is responsible for IgA-mediated

189 Immunoglobulin A (IgA), the major class of antibody secr

190 Immunoglobulin A (IgA), the most abundant human immunogl

191 a gonorrhoeae, produce proteases that cleave immunoglobulin A (IgA), the predominant immunoglobulin c

192 We hypothesized that immunoglobulin A (IgA), the predominant mucosal antibody

193 induced Frag C-specific mucosal and systemic immunoglobulin A (IgA)- and IgG-secreting cells, T-cell

194 nd CD8(+) cells and a sizeable population of immunoglobulin A (IgA)- and IgG-secreting plasma cells.

195 6 (IL-6) was required for the development of immunoglobulin A (IgA)- and T-helper 1 (Th1)-associated

196 tly generated and characterized a new murine immunoglobulin A (IgA)-class monoclonal antibody (MAb),

197 nd secondary chlamydial genital infection in immunoglobulin A (IgA)-deficient (IgA(-/-)) mice was not

198 sentation of ovalbumin (OVA) internalized as immunoglobulin A (IgA)-OVA via the IgA Fc receptor (Fcal

199 Humoral immune responses, particularly immunoglobulin A (IgA)-secreting B-1 cells, play a criti

200 Normal intestinal mucosa contains abundant immunoglobulin A (IgA)-secreting cells, which are genera

201 rus-specific serum antibodies and intestinal immunoglobulin A (IgA).

202 , bovine submaxillary gland mucin, and serum immunoglobulin A (IgA).

203 icrobial peptides, and mucosal production of immunoglobulin A (IgA).

204 ic coating of the intestinal microbiota with immunoglobulin A (IgA-SEQ) and show that high IgA coatin

205 We tested the ability of a human monoclonal immunoglobulin-A (IgA) antibody specific for Amb a I (A-

206 w that microbially driven dichotomous faecal immunoglobulin-A (IgA) levels in wild-type mice within t

207 The genetic component of Immunoglobulin-A (IgA) vasculitis is still far to be elu

208 tibodies to Helicobacter pylori [isotypes of immunoglobulins A (IgA), G (IgG), and M (IgM)], hepatiti

209 to characterize mucosal (salivary and fecal immunoglobulin A [IgA]) and cellular (NV-specific IgA an

210 cessible to a membrane-bound marker (dimeric immunoglobulin A [IgA]) internalized from either the api

211 We report isotype-specific (immunoglobulin A [IgA], IgE, IgG1, IgG4, and IgG) antibo

212 measure levels of total and Candida-specific immunoglobulin A(IgA) and IgG antibodies, including subc

213 H. pylori serum immunoglobulin A, IgG, and IgG subclass responses were d

214 antibody response, as well as a strong local immunoglobulin A immune response in the lung as determin

215 DMBT1(gp-340), mucin-7, secretory component, immunoglobulin A, immunoglobulin G, S100-A9, and lysozym

216 ubjects had a 4-fold rise in serum levels of immunoglobulin A, immunoglobulin M, or immunoglobulin G.

217 Serology screening of total immunoglobulin A in all patients may not be necessary in

218 ort study, the presence of parasite-specific immunoglobulin A in breast milk was associated with prot

219 llular permeability, normalized anti-gliadin immunoglobulin A in intestinal washes, and modulated the

220 es in sera and of peptide-specific secretory immunoglobulin A in nasal secretions.

221 the presence of elevated levels of anti-MBP immunoglobulin A in the tear fluid of the immunized anim

222 ling polymeric immunoglobulin receptor-bound immunoglobulin A is delivered to a Rab11-positive subapi

223 in serotypes 2 and 3, and although salivary immunoglobulin A is significantly increased in serotypes

224 Immunoglobulin A isolated from immunized animals bound M

225 onal antibody against PDC-E2 and AMA with an immunoglobulin A isotype.

226 yme-linked immunosorbent assay for secretory immunoglobulin A, lactoferrin, lysozyme, and interleukin

227 1.8-fold increase in total small intestinal immunoglobulin A levels (P = 0.003) and a 4.4-fold incre

228 range: 2.0-2.3 x 10(3)/microl, p = 0.05) and immunoglobulin A levels (range: 210-252 mg/dl, p = 0.04)

229 the monoclonal antibody, and serum anti-OmpW immunoglobulin A levels were elevated in a Crohn's disea

230 Salivary albumin and immunoglobulin A levels were relatively low in these pat

231 le family members showed only elevated serum immunoglobulin A levels.

232 obulin G titers (median, 1:51,200) and lower immunoglobulin A (median, 1:3,200) and immunoglobulin E

233 m cryptosporidium-infected patients and with immunoglobulin A monoclonal antibodies.

234 cal segmental glomerulosclerosis (FSGS), 57; immunoglobulin A nephritis, 22; membranoproliferative gl

235 HRa, 0.90; 95% CI, 0.32-2.52) but present in immunoglobulin A nephropathy (HRa, 0.74; 95% CI, 0.59-0.

236 ow T cells contribute to the pathogenesis of immunoglobulin A nephropathy (IgAN) has not been well de

237 identified multiple susceptibility loci for immunoglobulin A nephropathy (IgAN), the most common for

238 Concurrent immune diseases are common, and immunoglobulin A nephropathy may explain ascites in some

239 Immunoglobulin A nephropathy results from the abnormal d

240 confidence interval [95% CI], 1.05-1.31) for immunoglobulin A nephropathy to 2.09 (95% CI, 1.56-2.78)

241 iabetic nephropathy, membranous nephropathy, immunoglobulin A nephropathy, and autosomal dominant pol

242 ier for end-stage renal disease secondary to immunoglobulin A nephropathy.

243 luenza virus immunoglobulin G (P < .001) and immunoglobulin A (P < .001) titers than recipients of Fl

244 nificant increases in LAM-reactive secretory immunoglobulin A (P<.05).

245 GC origin identified 6 lines lacking surface immunoglobulin, a phenotype never seen among lines deriv

246 Transcytosis of polymeric immunoglobulin A (pIgA) across epithelial cells is media

247 We have previously reported that oligoclonal immunoglobulin A plasma cells infiltrate acute KD tissue

248 Immunoglobulin A plasma cells infiltrate inflamed tissue

249 lly, LAIV induced a greater vaccine-specific immunoglobulin A plasmablast response, as well as a grea

250 Treatment with intravenous immunoglobulins (a preparation that contained anti-A bet

251 Quantities of virus-specific immunoglobulin A produced by small intestinal lamina pro

252 creased small intestinal rotavirus-specific, immunoglobulin A-producing antibody-secreting cell conce

253 ccompanied by accumulation of liver-resident immunoglobulin-A-producing (IgA(+)) cells.

254 ORC2 impaired CD4(+) T cell accumulation and immunoglobulin A production and aberrantly induced the t

255 olled infections only slowly although normal immunoglobulin A production was observed.

256 S, whereas LPS immunization resulted in only immunoglobulin A production.

257 here the first structure of a member of the immunoglobulin A protease (IgAP) family at 1.75-A resolu

258 zing with a probe to iga, a gene encoding an immunoglobulin A protease of H. influenzae, clustered ap

259 This fraction was enriched in polymeric immunoglobulin A receptor and contained apical membrane

260 embrane transport proteins and the polymeric immunoglobulin A receptor traffic on the same vesicle.

261 ctron microscopy demonstrated that polymeric immunoglobulin A receptor was localized predominantly on

262 ccine by the intrarectal route and a limited immunoglobulin A response at the same site.

263 ith wild-type C. rodentium develop a mucosal immunoglobulin A response to EspB.

264 Moreover, a substantial mucosal immunoglobulin A response was induced in the respiratory

265 nths after the challenge; however, no plasma immunoglobulin A response was observed up to 10 months.

266 Rare mucosal immunoglobulin A responses and no measurable vaccine-eli

267 y an important role in the higher intestinal immunoglobulin A responses and protection rates induced

268 In contrast, adaptive immunoglobulin A responses to symbiotic bacteria regulat

269 In contrast, more mucosal immunoglobulin A responses were seen with LAIV.

270 anti-lipopolysaccharide immunoglobulin G and immunoglobulin A responses were significantly correlated

271 tination inhibition titers, enhanced mucosal immunoglobulin A responses, and enhanced antigen present

272 n introduced through microfold cells induces immunoglobulin A responses, antigen delivered by goblet

273 or optimal induction of protective secretory immunoglobulin A responses.

274 e with the development of commensal-specific immunoglobulin A responses.

275 Each had plasmablastic morphology, showed immunoglobulin A restriction, and was ALK positive and C

276 e and, if so, whether antireovirus secretory immunoglobulin A (S-IgA) is a necessary component of pro

277 ted inquiry into the regulation of secretory immunoglobulin A (S-IgA) responses by substance P (SP) a

278 ere seronegative at baseline, anti-rotavirus immunoglobulin A seroconversion rates after 3 vaccine do

279 S-transferase fusion protein showed frequent immunoglobulin A seroreactivity in CD (54% of patients),

280 otein C (PspC) binds to both human secretory immunoglobulin A (sIgA) and complement factor H (FH).

281 Secretory immunoglobulin A (SIgA) antibodies directed against the

282 Secretory immunoglobulin A (SIgA) antibodies reactive with the pio

283 In addition, secretory immunoglobulin A (sIgA) antibodies were detected in the

284 chemical approaches to investigate secretory immunoglobulin A (SIgA) as a substrate of BV-associated

285 PspK bound human secretory immunoglobulin A (sIgA) but not the complement regulator

286 As secretory immunoglobulin A (SIgA) deficiency in small airways has

287 Secretory immunoglobulin A (SIgA) enhances host-microbiota symbios

288 vestigated the role of whole human secretory immunoglobulin A (sIgA), M6 protein-specific sIgA, and M

289 ermore, it expresses receptors for secretory immunoglobulin A (SIgA), the main antibody in mucosal se

290 The binding of human secretory immunoglobulin A (SIgA), the primary immunoglobulin in t

291 ase and promotes retrotransport of secretory immunoglobulin A (SIgA)-gliadin complexes.

292 lication of SseB-MB induced gut and systemic immunoglobulin A, T-helper type 17 cell (Th17), and Th1

293 roconversion was defined as a 4-fold rise in immunoglobulin A titer from before the first RV1 dose to

294 Two of 15 workers at caterer A had elevated immunoglobulin A titers to an antigenically related Norw

295 zation and induction of immunoglobulin G and immunoglobulin A to all antigens tested, while causing n

296 sed levels of antiplatelet antibodies of the immunoglobulin A type in the milk of ITP patients compar

297 Circulating levels of immunoglobulin A, vascular cell adhesion molecule-1, mye

298 anti-galactose/N-acetylgalactosamine lectin immunoglobulin A was associated with protection from rei

299 Vaginal FIV-specific immunoglobulin A was present at high titer in three LMga

300 High levels of reovirus-specific immunoglobulin A were determined in the RALT fragment cu